Pulpotomy is now a recommended treatment for pulpitis in primary teeth with the advancement of dental biomaterials. However, there is deficient in clinical studies which evaluate the long-term prognosis of pulpotomy in primary teeth. Thus, the study was aimed to evaluate the efficacy of iRoot BP Plus and mineral trioxide aggregate (MTA) for pulpotomy in primary molars with the aid of intraoral endoscope and to explore the influencing factors. The teeth records with iRoot BP Plus and MTA were included. The gender, age, tooth position, clinical examination, radiographs, clinical procedures, coronal restoration and follow-up information were obtained. The outcomes were analyzed by Chi-square test, Kaplan-Meier method and Cox regression (P < 0.05). The study included 82 children with 157 teeth (113 in the iRoot BP Plus group and 44 in the MTA group). The treatment procedure and the follow-up were monitored with the assistance of intraoral endoscope. The average follow-up period was 1213 days for iRoot BP Plus and 1289 days for MTA. Kaplan-Meier analysis showed a 1-year cumulative survival rate of 100% for both groups. The 2-year cumulative survival rate was 98.2% for the iRoot BP Plus group and 100% for the MTA group. The 3-year cumulative survival rate was 97.3% for the iRoot BP Plus group and 97.7% for the MTA group, with no statistically significant difference. Cox proportional hazards model analysis revealed that factors including gender, age, tooth position, irrigation type, hemostasis time, and coronal restoration had no significant association with treatment success rates. iRoot BP Plus demonstrates clinical outcomes comparable to those of MTA in pulpotomy of primary molars. When coupled with accurate pulp diagnosis and an appropriate coronal restoration, both materials contribute to a favorable long-term prognosis. Furthermore, the intraoral endoscope plays a valuable role as an auxiliary tool for monitoring treatment quality.
Wang et al. (Fri,) studied this question.